Management of the insulin resistance syndrome.

C. Desouza; L. Gilling; V. Fonseca

doi:10.1007/s11892-001-0026-6

Management of the insulin resistance syndrome.

C. Desouza, L. Gilling, V. Fonseca

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.

Original language	English (US)
Pages (from-to)	140-147
Number of pages	8
Journal	Current diabetes reports
Volume	1
Issue number	2
DOIs	https://doi.org/10.1007/s11892-001-0026-6
State	Published - Oct 2001
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s11892-001-0026-6

Fingerprint Dive into the research topics of 'Management of the insulin resistance syndrome.'. Together they form a unique fingerprint.

Cite this

@article{ee5f7c41f556473e9e2f2843aa1b227e,

title = "Management of the insulin resistance syndrome.",

abstract = "The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.",

author = "C. Desouza and L. Gilling and V. Fonseca",

year = "2001",

month = oct,

doi = "10.1007/s11892-001-0026-6",

language = "English (US)",

volume = "1",

pages = "140--147",

journal = "Current Diabetes Reports",

issn = "1534-4827",

publisher = "Current Medicine Group",

number = "2",

}

TY - JOUR

T1 - Management of the insulin resistance syndrome.

AU - Desouza, C.

AU - Gilling, L.

AU - Fonseca, V.

PY - 2001/10

Y1 - 2001/10

N2 - The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.

AB - The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=0035497675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035497675&partnerID=8YFLogxK

U2 - 10.1007/s11892-001-0026-6

DO - 10.1007/s11892-001-0026-6

M3 - Review article

C2 - 12643110

AN - SCOPUS:0035497675

VL - 1

SP - 140

EP - 147

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 2

ER -